KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $3.6 billion.

  • Bausch Health Companies' Accumulated Expenses rose 6.26% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 6.26%. This contributed to the annual value of $3.5 billion for FY2024, which is 11.36% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Accumulated Expenses is $3.6 billion, which was up 3.72% from $3.5 billion recorded in Q2 2025.
  • Bausch Health Companies' Accumulated Expenses' 5-year high stood at $5.1 billion during Q2 2021, with a 5-year trough of $2.9 billion in Q1 2023.
  • For the 3-year period, Bausch Health Companies' Accumulated Expenses averaged around $3.3 billion, with its median value being $3.3 billion (2024).
  • As far as peak fluctuations go, Bausch Health Companies' Accumulated Expenses climbed by 18.85% in 2021, and later crashed by 41.11% in 2022.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Accumulated Expenses stood at $4.8 billion in 2021, then crashed by 37.63% to $3.0 billion in 2022, then grew by 4.85% to $3.1 billion in 2023, then grew by 11.36% to $3.5 billion in 2024, then rose by 6.26% to $3.6 billion in 2025.
  • Its last three reported values are $3.6 billion in Q3 2025, $3.5 billion for Q2 2025, and $3.4 billion during Q1 2025.